Institutional investors hold a majority ownership of ACT through the 96.18% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2014, these large investors purchased a net $18.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 6.6 Million shares of Actavis
WADDELL & REED INVESTMENT MANAGE... Bought 3.4 Million shares of Actavis
VIKING GLOBAL INVESTORS LP Bought 2.0 Million shares of Actavis